AKT1 and cancer: Interestingly, a large body of evidence is emerging to indicate that several signaling pathways are critically involved in mediating acquired resistance to chemotherapeutic drugs in human cancer, including PI3K/AKT, MEK/ERK, JNK and AMPK pathways [40], [41].